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S U M M A R Y
The inﬂuenza A(H1N1)pdm09 virus was detected in Cuba in May 2009. The introduction of a new virus
with increased transmissibility into a population makes surveillance of the pandemic strain to the
molecular level necessary. The aim of the present study was the molecular and phylogenetic analysis of
pandemic inﬂuenza A(H1N1)pdm09 strains that circulated in Cuba between May 2009 and August 2010.
Seventy clinical samples were included in the study. Nucleotide sequences from the hemagglutinin HA1
region segment were obtained directly from clinical samples. Genetic distances were calculated using
MEGA v.5.05. A phylogenetic tree was constructed using MrBayes v.3.1.2 software. Potential N-
glycosylation sites were predicted using NetNGlyc server 1.0. The 48 Cuban sequences of inﬂuenza
A(H1N1)pdm09 obtained were similar to the A/California/07/2009 (H1N1) vaccine strain. Most of the
Cuban strains belonged to clade 7. Cuban viruses showed amino acid changes, some of them located at
three antigenic sites: Ca, Sa, and Sb. Two dominant mutations were detected: P83S (100%) and S203T
(85.7%). Glycosylation site analysis revealed the gain of one site at position 162 in 13 sequences. The
ﬁndings in this study contribute to our understanding of the progress of the inﬂuenza A(H1N1)pdm09
virus, since this virus is at the starting point of its evolution in humans.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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The pandemic virus inﬂuenza A(H1N1)pdm09 was detected in
Cuba in May 2009. Since then, the virus has spread across the
country. The aim of the present study was the molecular and
phylogenetic analysis of inﬂuenza A(H1N1)pdm09 strains that
circulated in Cuba between May 2009 and August 2010.
2. Methods
A total of 70 clinical samples positive for inﬂuenza
A(H1N1)pdm09 virus were included in the study, representing
initial (n = 15), ﬁrst wave (n = 20), second wave (n = 20), and ﬁnal
period (n = 15) samples. Total viral RNA was automatically
extracted from clinical samples using the QIAamp Viral RNA
Mini Kit (Qiagen, USA) in a QIAcube extractor (Qiagen, USA).
Ampliﬁcation reactions were achieved following a previously* Corresponding author.
E-mail address: alexpr@ipk.sld.cu (A.P. Ramos).
1201-9712/$36.00 – see front matter  2013 International Society for Infectious Disea
http://dx.doi.org/10.1016/j.ijid.2013.01.028published protocol.1 Nucleotide sequences of PCR products were
determined using the BigDye GenomeLab Dye Terminator Cycle
Sequencing Kit (Beckman Coulter, USA). Genetic distances were
calculated in MEGA v.5.05 using the Kimura two-parameter model.
A phylogenetic tree was constructed using MrBayes v.3.1.2
software.2 The tree was visualized using Dendroscope v.2.7.4.
Potential N-glycosylation sites were predicted using NetNGlyc
server 1.0. Cuban sequences were deposited in the GenBank
database under accession numbers: HM159409.1–HM159418.1;
HM176606.1–HM176611.1; HQ190937–HQ190939, HQ190941;
and JQ922272–JQ922304.
3. Results and discussion
Sequence analysis of the 48 obtained partial HA1 segment
hemagglutinin of Cuban inﬂuenza A(H1N1)pdm09 sequences
showed an amino acid similarity of 98.8% with vaccine strain
inﬂuenza A/California/07/2009 (H1N1).
Phylogenetic analysis of the Cuban sequences showed that G7
was the most represented, harboring the S203T mutation locatedses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Phylogenetic relationships of the HA1 peptide of the inﬂuenza A(H1N1)pdm2009 viruses detected in Cuba. The phylogenetic tree was constructed using MrBayes
v.3.1.2 software, incorporating the HKY + G model of nucleotide substitution. The generation number and sample frequency sampling were ﬁxed to 5 000 000 and 1000,
respectively. Every clade was supported by Bayesian posterior probabilities (BPP).
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A further observation was the subgroup located in clade 7
(Figure 1), integrated with sequences obtained from clinical
samples collected during the last months of the epidemic. This
subgroup included 12 Cuban sequences and showed the A186T
mutation located at antigenic site Sb. The other Cuban sequences
were not included in any of the deﬁned clades, maybe because of
the studies describing seven clades completed the phylogeny with
a whole concatenated genome.
The most common change in Cuban sequences was P83S
(100%). Other important changes located at antigenic sites were
detected: S203T and D222E (Ca antigenic site); N156K and S162N(Sa antigenic site); A186T (Sb antigenic site). The frequencies of
occurrence of the mutations mentioned above are shown in
Figure 2.
Mutation S203T found in 85.7% of Cuban sequences was located
in the vicinity of the receptor binding domain. It has been reported
that this change emerged in a transient way in sequences of
inﬂuenza A H1N1 viruses collected from humans in 1934 and from
swine in 1976–77,4 showing that this amino acid change could
affect the infectivity and transmissibility of inﬂuenza
A(H1N1)pdm09 virus in humans.
The mutation S162N located at the antigenic site Sa, and
detected in Cuban sequences during the ﬁnal period of the
Figure 2. Frequencies of occurrence of the main mutations detected in Cuban sequences when compared with the vaccine strain inﬂuenza A/California/07/2009 (H1N1).
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was conﬁrmed that glycans added to positions 127, 155, and 162
could effectively block the immune reaction of antibodies elicited
against pandemic strains from the years 1918 and 2009.5
The mutation A186T was another change detected in Cuban
sequences. This mutation is located at antigenic site Sb in the
receptor binding site and appears in combination with mutations
N31D, S162N, and I172 V in six sequences. The same observation
was reported in sequences from the USA and Ecuador, with S162N
and A186T modulating antibody attachment.6 This is an important
ﬁnding since it could be an important step in the evolution of
inﬂuenza A(H1N1)pdm09.
In one Cuban sequence, the mutation N156K located at
antigenic site Sa was also detected. A previous report described
N156K and/or N125D as mutations associated with a diminished
A/California/07/2009 vaccine strain antibody recognition in
vaccinated individuals.7
The aspartic acid to glycine change at position 222 (D222G)
allows the virus to gain double speciﬁcity in receptor binding. This
change allows the virus to reach the lower respiratory tract,
causing an increase in severity of disease.8 None of the Cuban
sequences showed the D222G change, however a virus from a
patient suffering a mild disease harbored the D222E mutation
located at antigenic site Sa, a mutation also detected by others.9
Some authors have associated the D222G change with an increased
severity of the disease caused by inﬂuenza virus A(H1N1)pdm09.10
On the other hand, substitution D222E was not associated with
severity of the disease.9
This research constitutes the ﬁrst molecular study of the
inﬂuenza pandemic viruses circulating in Cuba in 2009–2010.
Cuban sequences were similar to vaccine strain inﬂuenza A/
California/07/2009 (H1N1). However, further antigenic analysis is
needed to assess the characteristics of sequenced viruses,speciﬁcally those that possess changes at antigenic and glycosyla-
tion sites of the hemagglutinin. Our ﬁndings, like those of other
studies, conﬁrm the genetic variability of the inﬂuenza
A(H1N1)pdm09 viruses and show the importance of systematic
molecular surveillance for the effective management of inﬂuenza
epidemics and pandemics.
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